Trial Profile
Adipose Dysfunction, Imaging, Physiology, and Outcomes With SGLT2i's for Sleep Apnea: The ADIPOSA Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2024
Price :
$35
*
At a glance
- Drugs Ertugliflozin (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- Acronyms ADIPOSA
- 12 Apr 2024 Status changed from not yet recruiting to recruiting.
- 01 Feb 2024 Planned initiation date changed from 1 Jan 2024 to 1 Feb 2024.
- 31 Jul 2023 Planned initiation date changed from 1 Jul 2023 to 1 Jan 2024.